GeneMate® targeted services now available - select the test that suits your needs.
For a better experience on GeneMate, enable JavaScript in your browser
25-04-2022
Stockholm, 21 April, 2022 – Cancer diagnostics company iCellate Medical AB announces collaboration with football star Olivia Schough. Olivia shares her story of hereditary cancer risk with the hope of helping others who are considering getting...
22-02-2022
February 10, 2022. Elthera AG, iCellate Medical AB, Targos Molecular Pathology GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of Kiel are proud to announce that the clinical trial for their...
10-02-2022
While writing about genetic variants we use the terms benign, pathogenic, and variant of unknown significance (VUS). We’d like to take a moment to describe how genetic variants are classified as such.. . The more common genetic sequencing becom...
12-01-2022
Calculate your risk for breast, ovarian, and prostate cancer. It can be hard to know if a hereditary cancer test is relevant for you. CanRisk is an online tool you can use to calculate th...
23-11-2021
Many families have a pretty good idea of who in the immediate family, if anyone, has been affected by what cancer type, and sometimes even as far out as aunts, uncles, and cousins. But as...
08-07-2021
How common is stomach cancer?1. Gastric cancer (also called stomach cancer) has historically been the most common form of cancer in the world. During the past decades the frequency has decreased, and today gastric cancer is the fifth most common canc...
01-07-2021
On June 17th, 2021, GeneMate® was accepted into the online database Orphanet, furthering iCellate’s goal of expanding access to genetic testing and cancer prevention.. In Orphanet’s words...
17-06-2021
In this blog post we will walk you through the various possible outcomes of your GeneMate® test.. A positive result means that a pathogenic variant was identified in one of the 41 genes that were analyzed. All genetic variants that are identified...
10-06-2021
Ever wonder what happens to your saliva sample after returning it to iCellate's lab? Learn how your sample is handled and how iCellate determines your hereditary cancer risk.....
17-05-2021
Hereditary pathogenic variants (mutations) are relatively rare and most individuals that get tested with GeneMate® will test negative – meaning that they will not have an increased risk of...
06-05-2021
How common is melanoma skin cancer?1. Melanoma skin cancer (referred to as melanoma from here on) is the sixth most common cancer type in Swedish men and the fifth most common in Swedish women. It is the most rapidly increasing cancer in Sweden, with...
03-05-2021
GeneMate® tests 41 genes, all of which play a role in regulating how cells grow, divide, or die. When cell regulation is not working correctly, the risk of uncontrolled cell growth and div...
27-04-2021
How common is prostate cancer? 1. Every fifth man in Sweden will be diagnosed with prostate cancer during his lifetime, resulting in approximately 10 000 diagnoses each year. It is the most common type of cancer amongst Swedish men, but als...
23-04-2021
In the Swedish healthcare system, families must fulfill specific criteria to be offered genetic testing for hereditary cancer. One such criteria is the occurrence of several related cancer...
15-04-2021
In an earlier post we wrote about hereditary colorectal cancer syndromes, which can be divided into Lynch syndrome and polyposis syndromes. In this post we will tell you more about the different polyposis syndromes, their causes, associated cancer ty...
13-04-2021
Stockholm, Sweden – April 12, 2021 - iCellate Medical AB, a Swedish cancer diagnostics company receives news of Swedac’s decision to certify according to ISO 15189:2012, Medical laboratori...
03-03-2021
How common is ovarian cancer?. Ovarian cancer is the seventh most common cancer in Swedish women and accounts 3% of all cancers in women1. The average lifetime risk of developing ovarian cancer is between 1–2%1,2. Ovarian cancer is difficult to...
24-02-2021
In an earlier post we wrote about hereditary colorectal cancer syndromes, which can be divided into Lynch syndrome and polyposis syndromes. Lynch syndrome constitutes about 1-3% of all colorectal cancer and in this post, we will tell you more about t...
15-02-2021
There may be several reasons you wish to take a genetic test. In families with suspected hereditary cancer genetic testing is used to determine whether the cancer is caused by a pathogenic...
03-02-2021
How common is breast cancer?. More than one in ten Swedish women will be diagnosed with breast cancer during their liftetime, which makes breast cancer the most common type of cancer in Swedish women1. The majority of women are diagnosed between 60 a...
01-12-2020
How common is colorectal cancer?. About 7000 people get diagnosed with colorectal cancer in Sweden each year1, which makes it the third most common cancer in Sweden. A majority of 75% are diagnosed at 65 years of age or older. Colon cancer is equally...
